Quality of life of postmenopausal women in the ATAC ("Arimidex", tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer

David Cella*, Lesley Fallowfield, Peter Barker, Jack Cuzick, Gershon Locker, Anthony Howell

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

203 Scopus citations

Fingerprint

Dive into the research topics of 'Quality of life of postmenopausal women in the ATAC ("Arimidex", tamoxifen, alone or in combination) trial after completion of 5 years' adjuvant treatment for early breast cancer'. Together they form a unique fingerprint.

Medicine and Dentistry

INIS

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science